Agilent (NYSE: A) Price Target Adjusted by HSBC Amid Strong Q2 Results and AI Growth

• HSBC adjusted its price target for Agilent (NYSE: A) to $165, indicating a potential upside of 22.19% from its trading price of $135.04, despite a downward revision from the previous $180.
• The scientific instrument maker reported robust second-quarter fiscal 2026 results, with revenues climbing 10% to $1.83 billion and non-GAAP earnings per share (EPS) reaching $1.49.
• Agilent raised its full fiscal year 2026 financial outlook, projecting revenues between $7.39 billion and $7.49 billion, and non-GAAP EPS in the range of $6.00 to $6.10, while also pursuing growth through AI collaboration and strong international sales.

On June 3, 2026, an analyst from HSBC adjusted the price target for Agilent (NYSE: A). Agilent is a leading scientific instrument maker with a significant global presence and a market capitalization of around $38.16 billion. The company provides essential instruments, software, and services to laboratories worldwide, solidifying its position in the healthcare technology sector.

The analyst lowered the price target to $165 from a previous $180. At the time of the announcement, Agilent was trading at $135.04. This new target suggests a potential upside of approximately 22.19% from that price, even with the downward revision from the prior target, highlighting continued confidence in Agilent stock.

This adjustment comes after Agilent reported strong second-quarter fiscal 2026 results. The company announced revenues rose 10% to $1.83 billion and posted a non-GAAP earnings per share (EPS) of $1.49. Non-GAAP EPS is a profit measure that excludes certain one-time expenses to show ongoing performance, offering a clearer view of Agilent's operational strength.

Following its strong performance, Agilent raised its financial outlook for the full fiscal year 2026. The company now projects revenues between $7.39 billion and $7.49 billion. It also anticipates a non-GAAP EPS in the range of $6.00 to $6.10 for the year, reflecting positive momentum for the scientific instrument market leader.

As highlighted by Business Wire, Agilent is also pursuing growth through a collaboration with OpenAI and BCG to deploy artificial intelligence, enhancing its technological edge. Additionally, as Zacks Investment Research notes, the company's reliance on international sales is a key factor for its financial resilience and growth potential in the global scientific instruments market.